SNN
Smith & Nephew SNATS Inc
NYSE: SNN · HEALTHCARE · MEDICAL DEVICES
$30.38
-2.25% today
Updated 2026-04-29
Market cap
$12.97B
P/E ratio
21.24
P/S ratio
2.10x
EPS (TTM)
$1.43
Dividend yield
2.57%
52W range
$27 – $38
Volume
0.9M
WallStSmart proprietary scores
62
out of 100
Grade: C+
Hold
Investment rating
7.3
Growth
B+7.5
Quality
B+6.0
Profitability
B8.0
Valuation
A4/9
Piotroski F-Score
Moderate
2.6
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$36.02
+18.56%
12-Month target
$32.39
+6.62%
Intrinsic (DCF)
$61.96
Margin of safety
+43.03%
0 Strong Buy1 Buy4 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $594.67M — positive
+ 43.03% below intrinsic value
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $5.21B | $5.55B | $5.81B | $6.18B | $6.16B |
| Net income | $223.00M | $263.00M | $412.00M | $626.46M | $330.82M |
| EPS | — | — | — | — | $1.43 |
| Free cash flow | $110.00M | $181.00M | $606.00M | $853.99M | $594.67M |
| Profit margin | 4.28% | 4.74% | 7.09% | 10.14% | 10.10% |
Peer comparison
Smart narrative
Smith & Nephew SNATS Inc trades at $30.38. representing a P/E of 21.24x trailing earnings. Our Smart Value Score of 62/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.55, it sits in the grey zone. TTM revenue stands at $6.16B. with profit margins at 10.10%. Our DCF model estimates intrinsic value at $61.96.
Frequently asked questions
What is Smith & Nephew SNATS Inc's stock price?
Smith & Nephew SNATS Inc (SNN) trades at $30.38.
Is Smith & Nephew SNATS Inc overvalued?
Smart Value Score 62/100 (Grade C+, Hold). DCF value $61.96.
What is the price target of Smith & Nephew SNATS Inc (SNN)?
The analyst target price is $36.02, representing +18.6% upside from the current price of $30.38.
What is the intrinsic value of Smith & Nephew SNATS Inc (SNN)?
Based on our DCF model, intrinsic value is $61.96, a +43.0% margin of safety versus $30.38.
What is Smith & Nephew SNATS Inc's revenue?
TTM revenue is $6.16B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
2.55 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio2.10x
ROE11.80%
Beta0.74
50D MA$33.56
200D MA$34.29
Shares out0.43B
Float0.84B
Short ratio—
Avg volume0.9M
Performance
1 week-4.82%
1 month-4.41%
3 months-9.74%
YTD-7.41%
1 year—
3 years—
5 years—